ACT1ON Phase 2 (SMART Pilot) and Phase 3 (Efficacy Trial Development)

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

November 12, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Diabetes Mellitus, Type 1Overweight and Obesity
Interventions
BEHAVIORAL

Hypocaloric, low carbohydrate diet

Participants will be advised on use of a hypocaloric, low carbohydrate diet using lifestyle counseling to include motivational interviewing and problem solving skills training strategies.

BEHAVIORAL

Hypocaloric, moderate low fat diet

Participants will be advised on use of a hypocaloric, moderate low fat diet using lifestyle counseling to include motivational interviewing and problem solving skills training strategies.

BEHAVIORAL

Mediterranean diet, no caloric restriction

Participants will be advised on use of a healthy Mediterranean-based eating plan using lifestyle counseling to include motivational interviewing and problem solving skills training strategies.

Trial Locations (2)

27599

University of North Carolina at Chapel Hill, Chapel Hill

94304

Stanford University, Palo Alto

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT03651622 - ACT1ON Phase 2 (SMART Pilot) and Phase 3 (Efficacy Trial Development) | Biotech Hunter | Biotech Hunter